11 Aug Nadda leads MPs from Karnataka & Kerala to accelerate TB-free India campaign

✎ The ‘TB-Mukt Bharat Abhiyaan’ is a 100-day, two-phase campaign under NTEP that intensified TB case detection and treatment in 347 high-priority districts and 1.58 lakh high-risk villages/urban wards.
Subject Relevance — Where This Topic Fits
- GS Paper II — Governance, Constitution, Polity, Social Justice and International Relations (Health Governance) | GS Paper III — Science and Technology (Public Health), Environment and Disaster Management (Disease Control)
- Prelims: National Tuberculosis Elimination Programme (NTEP), Sustainable Development Goals (SDG 3.3), Directly Observed Treatment Short-course (DOTS), Nikshay Poshan Yojana, Revised National Tuberculosis Control Programme (RNTCP), TB-Mukt Bharat Abhiyaan, Parliamentary Standing Committee on Health, District Collectors, Nikshay 2.0 portal
- Essay: Health as a Public Good: The Case for Universal Healthcare Coverage, The Role of Political Will in Achieving Sustainable Development Goals
Quick Revision: The ‘TB-Mukt Bharat Abhiyaan’ is a 100-day, two-phase campaign under NTEP that intensified TB case detection and treatment in 347 high-priority districts and 1.58 lakh high-risk villages/urban wards.
Why is this in the news?
The Union Health Minister chaired a high-level meeting with Members of Parliament from Karnataka and Kerala to review progress under the ‘TB-Mukt Bharat Abhiyaan’ and strategise for accelerated tuberculosis elimination, highlighting the integration of parliamentary oversight with district-level implementation mechanisms and community engagement.
Background
- Tuberculosis (TB) remains a significant public health challenge in India, accounting for approximately 27% of the global TB burden despite being preventable and curable.
- The National Tuberculosis Elimination Programme (NTEP), previously known as RNTCP, has undergone multiple revisions to align with the End TB Strategy of the World Health Organization.
- The ‘TB-Mukt Bharat Abhiyaan’ is a flagship initiative under NTEP, operationalised through two phases of the 100-Day Campaign, focusing on high-risk districts, villages, and urban wards to intensify case detection and treatment adherence.
- Parliamentary engagement in health governance has been institutionalised through consultative meetings with MPs to foster multi-stakeholder collaboration and ensure accountability in public health delivery.
- The meeting underscores the role of elected representatives in bridging the gap between national policy and grassroots implementation, particularly in states with high TB prevalence.
What is the ‘TB-Mukt Bharat Abhiyaan’ and its Governance Framework?
- The ‘TB-Mukt Bharat Abhiyaan’ is a time-bound, mission-mode campaign under the National Tuberculosis Elimination Programme (NTEP) to accelerate India’s progress towards TB elimination by 2025.
- The campaign operates through a two-phase 100-day model: Phase I started on 7 December 2024 and ended on 24 March 2025, targeting 347 high-priority districts, while Phase II started on 24 March 2026 and ended in July 2026, expanding to cover 1.58 lakh high-risk villages and urban wards across India.
- Key objectives include early case detection, ensuring 100% treatment coverage, reducing TB-related mortality, and addressing social determinants such as malnutrition and stigma through multi-sectoral interventions.
- The campaign leverages innovative patient-identification strategies, including community-based screening, digital tools (e.g., Nikshay 2.0 portal), and active case-finding in high-risk populations such as tribal communities, urban slums, and migrant workers.
- Parliamentary involvement is structured through consultative meetings with MPs to review progress, identify implementation bottlenecks, and foster district-level coordination with health authorities and district collectors.
- The campaign integrates patient-centric care models, including nutritional support under the Nikshay Poshan Yojana, counselling for treatment adherence, and post-treatment follow-up to prevent relapse and drug-resistant TB.
- India’s TB elimination strategy aligns with the WHO’s End TB Strategy, focusing on three pillars: integrated patient-centred care and prevention, bold policies and supportive systems, and intensified research and innovation.
- The campaign’s success metrics include the number of TB cases detected, treatment success rates, reduction in TB mortality, and community awareness levels, with real-time monitoring through the Nikshay platform.
Key Features
| Feature | Significance |
|---|---|
| 100-Day TB-Mukt Bharat Campaign (Phase II) | Accelerated case detection and treatment initiation through intensified screening in high-risk villages and urban wards, covering 1.58 lakh locations nationwide. |
| Patient-Centric Care Model | Shift from provider-driven to patient-focused TB care, ensuring dignity, adherence support, and post-treatment follow-up for improved outcomes. |
| Multi-Stakeholder Coordination | Involvement of district collectors, health institutions, and MPs to bridge gaps between policy and ground-level implementation. |
| Innovative Case-Finding Strategies | Use of AI-driven algorithms, digital health records, and community-led surveillance to identify undetected TB cases. |
| Political Ownership through MPs | Sustained parliamentary engagement to prioritize TB elimination, align resources, and foster public-private partnerships. |
Why it Matters
Public Health Impact
- Demonstrates India’s accelerated progress toward WHO’s End TB Strategy, with a 21% reduction in TB cases (2015–2024) and 92% treatment coverage.
- Reduces disease burden, economic losses (estimated at 1.5% of GDP annually), and mortality, particularly among vulnerable populations.
- Strengthens India’s global leadership in TB elimination, aligning with Sustainable Development Goal 3.3.
Governance & Institutional Strengthening
- Showcases the ‘Whole-of-Government’ approach, integrating health, rural development, and local governance for holistic TB control.
- Enhances inter-departmental synergy (e.g., education for awareness, MSME for livelihood support for recovered patients).
- Establishes a precedent for parliamentary oversight in public health emergencies.
Socio-Economic Benefits
- Prevents loss of productivity by enabling early diagnosis and treatment, particularly in high-risk demographic groups.
- Reduces out-of-pocket expenditure for households affected by TB, improving financial inclusion.
- Supports SDG targets on poverty reduction (SDG 1) and decent work (SDG 8) by mitigating TB’s economic impact.
Challenges
1. Diagnostic Gaps in Hard-to-Reach Areas
- Persistent under-detection in tribal, remote, and urban slum populations due to limited healthcare access.
- Need for mobile diagnostic units and community health workers to bridge last-mile delivery gaps.
UPSC Link: GS2: Health Infrastructure
2. Drug-Resistant TB (DR-TB) Management
- Rising prevalence of multi-drug-resistant TB (MDR-TB) requires advanced diagnostics and longer, costlier treatment regimens.
- Ensuring uninterrupted drug supply and adherence support to prevent treatment failure.
UPSC Link: GS2: Health Services
3. Stigma and Low Awareness
- Social stigma discourages TB reporting, leading to delayed diagnosis and treatment.
- Requires sustained IEC (Information, Education, Communication) campaigns to dispel myths and promote early care-seeking.
UPSC Link: GS2: Social Justice
4. Private Sector Engagement
- Inadequate reporting and non-standard treatment by private practitioners undermines national TB control efforts.
- Mandatory notification under the Nikshay portal and incentives for compliant providers are critical.
UPSC Link: GS2: Health Governance
5. Data Integration and Surveillance
- Fragmented health data systems hinder real-time monitoring of TB trends and program performance.
- Strengthening the Ni-Kshay platform and interoperability with Ayushman Bharat Digital Mission (ABDM) is essential.
UPSC Link: GS2: E-Governance
6. Funding and Resource Mobilisation
- Sustained financing for TB programs amid competing health priorities requires innovative financing models.
- Exploring public-private partnerships and global health funding mechanisms (e.g., Global Fund to Fight AIDS, TB, and Malaria).
UPSC Link: GS2: Health Financing
Challenges — UPSC Perspective
| Issue | Concern |
|---|---|
| Under-Reporting in Private Sector | Non-compliance with mandatory TB notification leads to gaps in national data. |
| MDR-TB Prevalence | Higher treatment costs and longer durations strain health systems and patient adherence. |
| Geographical Disparities | Hilly, tribal, and urban slum areas face inadequate diagnostic and treatment facilities. |
| Stigma and Discrimination | Delays in care-seeking due to fear of social ostracization. |
| Supply Chain Bottlenecks | Irregular availability of TB drugs and diagnostics in peripheral health centers. |
Government Initiatives — Must-Memorise for Prelims
- Nikshay Poshan Yojana (Nutritional support for TB patients)
- Ayushman Bharat Health and Wellness Centres (AB-HWCs) for TB screening
Way Forward
- Scale up mobile diagnostic units and telemedicine services in high-risk districts to improve early detection.
- Strengthen the Ni-Kshay platform with real-time data analytics for targeted interventions and monitoring.
- Expand mandatory TB notification compliance among private healthcare providers through incentives and penalties.
- Launch region-specific awareness campaigns in tribal, coastal, and urban slum areas to combat stigma.
- Enhance DR-TB management by scaling up rapid molecular diagnostics (e.g., CBNAAT, TruNat) and shorter treatment regimens.
- Integrate TB screening with existing health programs (e.g., Ayushman Bharat, Poshan Abhiyaan) for comprehensive coverage.
- Foster public-private partnerships to leverage corporate social responsibility (CSR) funds for TB elimination initiatives.
- Conduct periodic state-wise reviews with district collectors and MPs to ensure accountability and resource allocation.
UPSC Value Addition
Keywords for Mains Answer-Writing
Tuberculosis elimination · National Strategic Plan for TB Elimination · 100-Day TB-Mukt Bharat Abhiyaan · Patient-centric TB care · Multi-stakeholder convergence · District-level monitoring · Community engagement · WHO Global TB Report 2025 · TB treatment coverage · High-burden districts · Parliamentary role in public health · Innovative case-finding strategies
Concept Flow
High TB burden in India → Recognition as a public health emergency → Formulation of National Strategic Plan (NSP) for TB Elimination → Launch of 100-Day TB-Mukt Bharat Campaign → Multi-stakeholder coordination (MPs, district collectors, health institutions) → Intensified case-finding and patient-centric care → Reduction in TB incidence and mortality → Alignment with SDG 3.3 (Good Health and Well-being) → Global recognition of India’s progress.
Prelims Practice Questions
Q1. Consider the following statements regarding the 100-Day TB-Mukt Bharat Abhiyaan:
1. The first phase covered 347 high-priority districts.
2. The second phase included approximately 1.58 lakh high-risk villages and urban wards.
3. The campaign screened over 2.02 crore individuals and detected 7 lakh new TB cases.
How many of the above statements are correct?
- Only one
- Only two
- All three
- None
Answer: All three — Statement 1 and 2 are correct as per the official data. Statement 3 is incorrect; the campaign screened 2.02 crore individuals but detected 7 lakh new TB cases, which is not explicitly stated as a screening figure.
Q2. Assertion (A): The National Strategic Plan for TB Elimination aims for a 95% reduction in TB incidence by 2025.
Reason (R): The plan prioritizes patient-centric care and innovative case-finding strategies to achieve its goals.
Options:
A. Both A and R are true, and R is the correct explanation of A.
B. Both A and R are true, but R is not the correct explanation of A.
C. A is true, but R is false.
D. A is false, but R is true.
Answer: ? — Assertion (A) is false; the National Strategic Plan targets a 90% reduction in TB incidence by 2025, not 95%. Reason (R) is true and aligns with the plan’s approach.
Q3. Match the following phases of the TB-Mukt Bharat Abhiyaan with their respective timelines:
Column I (Phase) | Column II (Timeline)
——————————–|————————
1. First Phase | A. 24 March 2026 – 4 July 2026
2. Second Phase | B. 7 December 2024 – 24 March 2025
Options:
A. 1-B, 2-A
B. 1-A, 2-B
C. 1-A, 2-A
D. 1-B, 2-B
Answer: ? — The first phase of the 100-Day TB-Mukt Bharat Abhiyaan ran from 7 December 2024 to 24 March 2025, while the second phase operated from 24 March 2026 to 4 July 2026.
Mains Practice Question
✍ The Union Government’s ‘TB-Mukt Bharat Abhiyaan’ represents a multi-dimensional approach to tuberculosis elimination through innovation, patient-centric care, and multi-stakeholder convergence. Critically examine the strategic pillars of this initiative and evaluate its progress in the context of the WHO Global TB Report 2025. (15 Marks)
Approach: MODEL-ANSWER SKELETON:
1. **Strategic Pillars of TB-Mukt Bharat Abhiyaan** (6 points, 100 words):
– **Patient-centric care**: Emphasis on dignity, support systems, and reducing stigma (align with National Strategic Plan for TB Elimination 2017–2025).
– **Innovative case-finding**: Use of AI-driven screening, digital health records, and community-based detection (cite examples like Nikshay Poshan Yojana and Nikshay Mitra).
– **Multi-stakeholder convergence**: Integration of Parliamentarians, district collectors, ASHAs, and NGOs for ground-level implementation (reference today’s meeting with MPs from Karnataka and Kerala).
– **100-Day Campaigns**: Phased implementation with measurable targets (first phase: 347 high-burden districts; second phase: 1.58 lakh high-risk villages/wards).
– **Data-driven monitoring**: Real-time dashboards, district-level accountability, and periodic reviews (reference role of District Collectors and health institutions).
– **Community engagement**: Jan Andolan for TB elimination, leveraging local leaders and influencers.
2. **Progress Evaluation** (6 points, 100 words):
– **Treatment coverage**: 92% achieved (WHO Global TB Report 2025), exceeding the global average.
– **Incidence reduction**: 21% decline from 2015–2024, nearly double the global pace (WHO data).
– **Challenges**: Persistent gaps in urban slums, migrant populations, and drug-resistant TB; need for sustained political will.
– **Comparative advantage**: India’s progress outpaces high-burden countries like Indonesia and Nigeria (WHO 2025).
– **Role of Parliamentarians**: Today’s meeting highlights their function as ‘agents of change’ in public health governance.
– **Future roadmap**: Scaling up preventive therapy, addressing social determinants, and strengthening health systems.
3. **Critical Perspective** (3 points, 50 words):
– **Strengths**: Scalability, innovation, and convergence model.
– **Limitations**: Over-reliance on campaigns; need for systemic integration.
– **Way forward**: Institutionalize multi-stakeholder models beyond ad-hoc initiatives.
Source: PIB (Press Information Bureau)
Generated by AanyaAi for educational purpose.
- Premature Redemption of SGB 2018-19 Series VI: Key Facts for UPSC 2026 - August 11, 2026
- लोकसभा में गतिरोध, बिना चर्चा पास हुए दो विधेयक: ‘केरल’ से ‘केरलम’ में बदलाव - August 11, 2026
- Lok Sabha passes Kerala name change, co-op bills amid Opposition protest - August 11, 2026

No Comments